Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001615774-17-000809
Filing Date
2017-02-27
Accepted
2017-02-27 16:34:16
Documents
4
Period of Report
2017-02-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A s105424_pre14a.htm PRE 14A 637956
2 EXHIBIT A s105424_exa.htm EX-99 925
3 GRAPHIC logo_pre14a.jpg GRAPHIC 19650
4 GRAPHIC pg1img1_exa.jpg GRAPHIC 303268
  Complete submission text file 0001615774-17-000809.txt   1085029
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-37606 | Film No.: 17642227
SIC: 8731 Services-Commercial Physical & Biological Research